BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Nie C. KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma. Anticancer Drugs 2022. [PMID: 35946516 DOI: 10.1097/CAD.0000000000001329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Liu X, Chen Y, Xu R, He S, Khan R. KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/1556485] [Reference Citation Analysis]